Lower β₂*-Nicotinic Acetylcholine Receptor Availability in Smokers With Schizophrenia

From the Psychiatry Service, VA Connecticut Healthcare System, West Haven, Conn; the Abraham Ribicoff Research Facilities, Connecticut Mental Health Center, New Haven, Conn.; the Department of Psychiatry, Yale University School of Medicine, New Haven, Conn.; and the Institute for Neurodegenerative Disorders, New Haven, Conn.

From the Psychiatry Service, VA Connecticut Healthcare System, West Haven, Conn; the Abraham Ribicoff Research Facilities, Connecticut Mental Health Center, New Haven, Conn.; the Department of Psychiatry, Yale University School of Medicine, New Haven, Conn.; and the Institute for Neurodegenerative Disorders, New Haven, Conn.

From the Psychiatry Service, VA Connecticut Healthcare System, West Haven, Conn; the Abraham Ribicoff Research Facilities, Connecticut Mental Health Center, New Haven, Conn.; the Department of Psychiatry, Yale University School of Medicine, New Haven, Conn.; and the Institute for Neurodegenerative Disorders, New Haven, Conn.

From the Psychiatry Service, VA Connecticut Healthcare System, West Haven, Conn; the Abraham Ribicoff Research Facilities, Connecticut Mental Health Center, New Haven, Conn.; the Department of Psychiatry, Yale University School of Medicine, New Haven, Conn.; and the Institute for Neurodegenerative Disorders, New Haven, Conn.

From the Psychiatry Service, VA Connecticut Healthcare System, West Haven, Conn; the Abraham Ribicoff Research Facilities, Connecticut Mental Health Center, New Haven, Conn.; the Department of Psychiatry, Yale University School of Medicine, New Haven, Conn.; and the Institute for Neurodegenerative Disorders, New Haven, Conn.

From the Psychiatry Service, VA Connecticut Healthcare System, West Haven, Conn; the Abraham Ribicoff Research Facilities, Connecticut Mental Health Center, New Haven, Conn.; the Department of Psychiatry, Yale University School of Medicine, New Haven, Conn.; and the Institute for Neurodegenerative Disorders, New Haven, Conn.

From the Psychiatry Service, VA Connecticut Healthcare System, West Haven, Conn; the Abraham Ribicoff Research Facilities, Connecticut Mental Health Center, New Haven, Conn.; the Department of Psychiatry, Yale University School of Medicine, New Haven, Conn.; and the Institute for Neurodegenerative Disorders, New Haven, Conn.

From the Psychiatry Service, VA Connecticut Healthcare System, West Haven, Conn; the Abraham Ribicoff Research Facilities, Connecticut Mental Health Center, New Haven, Conn.; the Department of Psychiatry, Yale University School of Medicine, New Haven, Conn.; and the Institute for Neurodegenerative Disorders, New Haven, Conn.

From the Psychiatry Service, VA Connecticut Healthcare System, West Haven, Conn; the Abraham Ribicoff Research Facilities, Connecticut Mental Health Center, New Haven, Conn.; the Department of Psychiatry, Yale University School of Medicine, New Haven, Conn.; and the Institute for Neurodegenerative Disorders, New Haven, Conn.